TargetMol

SU-9516

Product Code:
 
TAR-T8819
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8819-1mg1mg£144.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-1mL1 mL * 10 mM (in DMSO)£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-5mg5mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-10mg10mg£209.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-25mg25mg£279.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-50mg50mg£342.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-100mg100mg£424.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8819-500mg500mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
SU9516 is a selectively potent ATP-competitive inhibitor of CDKs.
CAS:
666837-93-0
Formula:
C13H11N3O2
Molecular Weight:
241.25
Pathway:
Cell Cycle/Checkpoint
Purity:
0.9991
SMILES:
COc1ccc2NC(=O)C(=Cc3cnc[nH]3)c2c1
Target:
CDK

References

Collins I , Garrett M D . Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors[J]. Current Opinion in Pharmacology, 2005, 5(4):366-373. Guo Q , Jin L , Zhu H Y , et al. CDK inhibitor SU9516 induces tetraploid blastocyst formation from parthenogenetically activated porcine embryos[J]. Biotechnology Letters, 2017, 39(7):951-957.